Home › Funds › KORNITZER CAPITAL MANAGEMENT INC /KS › ABT

KORNITZER CAPITAL MANAGEMENT INC /KS position in ABT

ABBOTT LABORATORIES · Health Care

KORNITZER CAPITAL MANAGEMENT INC /KS reported holding 348,043 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$34.4M, representing 0.72% of its reported portfolio and ranking #33 among its reported holdings. KORNITZER CAPITAL MANAGEMENT INC /KS has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)348.04K sh
Reported value held$34.40M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How KORNITZER CAPITAL MANAGEMENT INC /KS's ABT position evolved

KORNITZER CAPITAL MANAGEMENT INC /KS first disclosed a stake in ABT in Q3 2023 at 396,851 shares (US$38.4M). The position peaked in Q2 2025 at 386,019 shares, worth US$52.5M. Across 13 filings, KORNITZER CAPITAL MANAGEMENT INC /KS increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 348,043 shares valued at US$34.4M — a reduction of -2,454 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 396.85K $38.44M New
Q4 2023 347.37K $38.23M Reduce
Q1 2024 375.62K $42.69M Add
Q2 2024 378.95K $39.38M Add
Q3 2024 383.30K $43.70M Add
Q4 2024 392.61K $44.41M Add
Q1 2025 388.48K $51.53M Reduce
Q2 2025 386.02K $52.50M Reduce
Q3 2025 383.17K $51.32M Reduce
Q4 2025 377.28K $47.27M Reduce
Q1 2026 369.76K $37.96M Reduce
Q2 2026 350.50K $31.80M Reduce
Q3 2026 348.04K $34.40M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has KORNITZER CAPITAL MANAGEMENT INC /KS held ABT?

KORNITZER CAPITAL MANAGEMENT INC /KS has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is KORNITZER CAPITAL MANAGEMENT INC /KS's current position in ABT?

As of Q3 2026, KORNITZER CAPITAL MANAGEMENT INC /KS holds 348.04K shares of ABT (ABBOTT LABORATORIES), valued at $34.40M, representing 0.72% of its reported portfolio and ranking #33.

Has KORNITZER CAPITAL MANAGEMENT INC /KS been buying or selling ABT?

In the latest 13F filing (Q3 2026), KORNITZER CAPITAL MANAGEMENT INC /KS reduced its position in ABT. The position peaked in Q2 2025 at 386.02K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.